Lung Cancer Screening Market Report 2026
Download Free Sample Buy Now
Lung Cancer Screening Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Lung Cancer Screening Market Report 2026

Global Outlook – By Diagnosis Type (Low Dose Spiral Computed Tomography Scan, Chest-X-Ray), By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), By Age Group (50 And Older, Below 50), By End-User (Hospitals And Clinics, Diagnostic Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Lung Cancer Screening Market Overview

• Lung Cancer Screening market size has reached to $3.33 billion in 2025

• Expected to grow to $5.24 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%

• Growth Driver: Rise In Smoking Rates Fueling The Growth Of The Market Due To Increasing Tobacco Accessibility And Health Awareness

• Market Trend: Innovations In Artificial Intelligence (AI) Technology Enhance Early Detection And Diagnostic Precision In Chest Imaging

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lung Cancer Screening Market?

Lung cancer screening is a preventive approach aimed at identifying cancer in the lungs at an early stage, often before any noticeable symptoms develop. It focuses on individuals who may have a higher risk due to specific health or lifestyle factors. The purpose of this process is to detect any unusual changes or growths in the lung tissue early, which can help improve the chances of effective treatment and reduce the overall impact of the disease.

The main diagnosis types of lung cancer screening include low-dose spiral computed tomography scans and chest X-rays. Low-dose spiral computed tomography scan refers to an imaging technique that uses low-dose radiation to create detailed cross-sectional images of the lungs, enabling early detection of lung abnormalities with high sensitivity. It is used for different cancer types, such as non-small cell lung cancer and small cell lung cancer, for different age groups, including 50 and older and below 50. It is used by several end-users, including hospitals and clinics, diagnostic centers, and others.

Lung Cancer Screening Market Global Report 2026 Market Report bar graph

What Is The Lung Cancer Screening Market Size and Share 2026?

The lung cancer screening market size has grown strongly in recent years. It will grow from $3.33 billion in 2025 to $3.65 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising incidence of lung cancer among aging populations, increased awareness of early screening benefits, expansion of diagnostic imaging infrastructure, improvements in ct imaging technology, adoption of guideline-based screening protocols.

What Is The Lung Cancer Screening Market Growth Forecast?

The lung cancer screening market size is expected to see strong growth in the next few years. It will grow to $5.24 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted diagnostic workflows, expansion of population-based screening programs, growing focus on personalized risk assessment, rising investments in early cancer detection technologies, increasing healthcare policy support for screening. Major trends in the forecast period include increasing adoption of low-dose ct screening programs, rising integration of ai in imaging analysis, growing focus on high-risk population screening, expansion of preventive oncology initiatives, enhanced emphasis on early lung cancer detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Lung Cancer Screening Market Segmentation

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

3) By Age Group: 50 And Older, Below 50

4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

What Is The Driver Of The Lung Cancer Screening Market?

The rising smoking rates are expected to propel the growth of the lung cancer screening market going forward. Smoking is the practice of breathing in smoke from burning substances, typically tobacco, through the mouth and lungs. The rise in smoking rates is due to increasing stress levels, leading more people to turn to smoking as a coping mechanism. Lung cancer screening is helpful in addressing rising smoking rates by enabling early detection of smoking-related health risks, which can motivate individuals to quit and support broader public health efforts in reducing tobacco use For instance, in October 2024, the Office for Health Improvement & Disparities, a UK-based government organisation, the prevalence of current smokers in the routine and manual occupation group (aged 18 to 64) in 2023 was 19.5%. Therefore, the rising smoking rates are driving the growth of the lung cancer screening industry.

Key Players In The Global Lung Cancer Screening Market

Major companies operating in the lung cancer screening market are Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation

Global Lung Cancer Screening Market Trends and Insights

Major companies operating in the lung cancer screening market are focusing on developing advanced solutions, such as normal flagging, to enhance diagnostic accuracy, reduce false positives, and improve early detection of cancerous nodules. Normal flagging refers to a technological feature in lung cancer screening that automatically identifies and flags scans with no abnormal findings, helping prioritize cases that need further review. For instance, in May 2025, Lunit Inc., a South Korea-based medical technology company, launched INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which is now CE MDR-certified for deployment across Europe. Designed to assist radiologists with improved diagnostic accuracy and workflow efficiency, the solution detects 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and introduces features such as current-prior image comparison to support early disease detection and clinical decision-making.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Lung Cancer Screening Market?

In May 2025, Johnson & Johnson MedTech, a US-based healthcare technology company, partnered with Qure.ai to boost early detection of lung cancer in India. With this partnership, Johnson & Johnson MedTech aimed to enhance its AI-driven diagnostic capabilities and expand access to early-stage lung-cancer screening by establishing AI-led Incidental Pulmonary Nodule (IPN) detection clinics across major hospitals in India. QURE AI TECHNOLOGIES PRIVATE LIMITED is an India-based healthcare technology company that specialises in AI-powered medical-imaging solutions (X-ray and CT) for automated lung-nodule detection, triage, and IPN management.

Regional Outlook

North America was the largest region in the lung cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lung Cancer Screening Market?

The lung cancer screening market includes revenues earned by entities by providing services such as radiology interpretation, diagnostic follow-up procedures, patient risk assessment, and telehealth consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lung Cancer Screening Market Report 2026?

The lung cancer screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Lung Cancer Screening Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.65 billion
Revenue Forecast In 2035 $5.24 billion
Growth Rate CAGR of 9.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Diagnosis Type, Cancer Type, Age Group, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lung Cancer Screening Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lung Cancer Screening Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lung Cancer Screening Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lung Cancer Screening Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Low-Dose Ct Screening Programs

4.2.2 Rising Integration Of Ai In Imaging Analysis

4.2.3 Growing Focus On High-Risk Population Screening

4.2.4 Expansion Of Preventive Oncology Initiatives

4.2.5 Enhanced Emphasis On Early Lung Cancer Detection

5. Lung Cancer Screening Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Centers

5.3 Oncology Screening Centers

5.4 Public Health Screening Programs

5.5 Preventive Care Facilities

6. Lung Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lung Cancer Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lung Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lung Cancer Screening Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lung Cancer Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lung Cancer Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lung Cancer Screening Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lung Cancer Screening Market Segmentation

9.1. Global Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

9.2. Global Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Small Cell Lung Cancer, Small Cell Lung Cancer

9.3. Global Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50 And Older, Below 50

9.4. Global Lung Cancer Screening Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Centers, Other End-Users

9.5. Global Lung Cancer Screening Market, Sub-Segmentation Of Low Dose Spiral Computed Tomography Scan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Screening, Diagnostic, Follow-Up

9.6. Global Lung Cancer Screening Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Posterior Anterior, Lateral, Portable

10. Lung Cancer Screening Market Regional And Country Analysis

10.1. Global Lung Cancer Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lung Cancer Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lung Cancer Screening Market

11.1. Asia-Pacific Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lung Cancer Screening Market

12.1. China Lung Cancer Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lung Cancer Screening Market

13.1. India Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lung Cancer Screening Market

14.1. Japan Lung Cancer Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lung Cancer Screening Market

15.1. Australia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lung Cancer Screening Market

16.1. Indonesia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lung Cancer Screening Market

17.1. South Korea Lung Cancer Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lung Cancer Screening Market

18.1. Taiwan Lung Cancer Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lung Cancer Screening Market

19.1. South East Asia Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lung Cancer Screening Market

20.1. Western Europe Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lung Cancer Screening Market

21.1. UK Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lung Cancer Screening Market

22.1. Germany Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lung Cancer Screening Market

23.1. France Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lung Cancer Screening Market

24.1. Italy Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lung Cancer Screening Market

25.1. Spain Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lung Cancer Screening Market

26.1. Eastern Europe Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lung Cancer Screening Market

27.1. Russia Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lung Cancer Screening Market

28.1. North America Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lung Cancer Screening Market

29.1. USA Lung Cancer Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lung Cancer Screening Market

30.1. Canada Lung Cancer Screening Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lung Cancer Screening Market

31.1. South America Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lung Cancer Screening Market

32.1. Brazil Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lung Cancer Screening Market

33.1. Middle East Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lung Cancer Screening Market

34.1. Africa Lung Cancer Screening Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Lung Cancer Screening Market, Segmentation By Diagnosis Type, Segmentation By Cancer Type, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lung Cancer Screening Market Regulatory and Investment Landscape

36. Lung Cancer Screening Market Competitive Landscape And Company Profiles

36.1. Lung Cancer Screening Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Lung Cancer Screening Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Lung Cancer Screening Market Company Profiles

36.3.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Lung Cancer Screening Market Other Major And Innovative Companies

Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc.

38. Global Lung Cancer Screening Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lung Cancer Screening Market

40. Lung Cancer Screening Market High Potential Countries, Segments and Strategies

40.1 Lung Cancer Screening Market In 2030 - Countries Offering Most New Opportunities

40.2 Lung Cancer Screening Market In 2030 - Segments Offering Most New Opportunities

40.3 Lung Cancer Screening Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Lung Cancer Screening Market, Overview Of Key Products - Product Examples
  • Table 2: Global Lung Cancer Screening Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Lung Cancer Screening Market, Supply Chain Analysis
  • Table 4: Global Lung Cancer Screening Market, Major Raw Material Providers
  • Table 5: Global Lung Cancer Screening Market, Major Resource Providers
  • Table 6: Global Lung Cancer Screening Market, Major Manufacturers (Suppliers)
  • Table 7: Global Lung Cancer Screening Market, Major Distributors And Channel Partners
  • Table 8: Global Lung Cancer Screening Market, Key Technologies & Future Trends
  • Table 9: Global Lung Cancer Screening Market, Major Trends
  • Table 10: Global Lung Cancer Screening Market, Major End Users
  • Table 11: Global Lung Cancer Screening Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Lung Cancer Screening Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Lung Cancer Screening Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Lung Cancer Screening Market - TAM, US$ Billion, 2025
  • Table 15: Global Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Lung Cancer Screening Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Lung Cancer Screening Market, Sub-Segmentation Of Low Dose Spiral Computed Tomography Scan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Lung Cancer Screening Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Lung Cancer Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Lung Cancer Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Lung Cancer Screening Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Lung Cancer Screening Market - Company Scoring Matrix
  • Table 97: Abbott Laboratories Inc. Financial Performance
  • Table 98: Canon Inc. Financial Performance
  • Table 99: Siemens Healthineers AG Financial Performance
  • Table 100: Koninklijke Philips N.V. Financial Performance
  • Table 101: GE Healthcare Technologies Inc. Financial Performance
  • Table 102: Global Lung Cancer Screening Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Lung Cancer Screening Market, Competitive Dashboard
  • Table 104: Global Lung Cancer Screening Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Lung Cancer Screening Market Size Gain ($ Billion), Segmentation By Diagnosis Type, 2025 – 2030
  • Table 106: Global, Lung Cancer Screening Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Table 107: Global, Lung Cancer Screening Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

    Figure 1: Global Lung Cancer Screening Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Lung Cancer Screening Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Lung Cancer Screening Market, Supply Chain Analysis
  • Figure 4: Global Lung Cancer Screening Market, Major Raw Material Providers
  • Figure 5: Global Lung Cancer Screening Market, Major Resource Providers
  • Figure 6: Global Lung Cancer Screening Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Lung Cancer Screening Market, Major Distributors And Channel Partners
  • Figure 8: Global Lung Cancer Screening Market, Key Technologies & Future Trends
  • Figure 9: Global Lung Cancer Screening Market, Major Trends
  • Figure 10: Global Lung Cancer Screening Market, Major End Users
  • Figure 11: Global Lung Cancer Screening Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Lung Cancer Screening Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Lung Cancer Screening Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Lung Cancer Screening Market - TAM, US$ Billion, 2025
  • Figure 15: Global Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Lung Cancer Screening Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Lung Cancer Screening Market, Sub-Segmentation Of Low Dose Spiral Computed Tomography Scan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Lung Cancer Screening Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Lung Cancer Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Lung Cancer Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Lung Cancer Screening Market, Segmentation By Diagnosis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Lung Cancer Screening Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Lung Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Lung Cancer Screening Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Lung Cancer Screening Market - Company Scoring Matrix
  • Figure 97: Abbott Laboratories Inc. Financial Performance
  • Figure 98: Canon Inc. Financial Performance
  • Figure 99: Siemens Healthineers AG Financial Performance
  • Figure 100: Koninklijke Philips N.V. Financial Performance
  • Figure 101: GE Healthcare Technologies Inc. Financial Performance
  • Figure 102: Global Lung Cancer Screening Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Lung Cancer Screening Market, Competitive Dashboard
  • Figure 104: Global Lung Cancer Screening Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Lung Cancer Screening Market Size Gain ($ Billion), Segmentation By Diagnosis Type, 2025 – 2030
  • Figure 106: Global, Lung Cancer Screening Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Figure 107: Global, Lung Cancer Screening Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Fraud Detection and Prevention Market Report 2026 - Global Outlook – By Fraud Type (Check Fraud, Identity Fraud, Internet Or Online Fraud, Investment Fraud, Payment Frauds, Insurance Fraud, Other Fraud Types ), By Deploy...

Financial Fraud Detection Software Market Report 2026 - Global Outlook – By Component (Solution, Service), By Fraud Type (Money Laundering, Identity Theft, Debit And Credit Card Frauds, Claim Frauds, Transfer Frauds, Oth...

Payment Monitoring Market Report 2026 - Global Outlook – By Type (Case Management, Dashboard And Reporting), By Deployment (Cloud, On-premise), By Organization Size (Large Enterprises, Small And Medium Enterprises), By A...

eCommerce Fraud Detection And Prevention Market Report 2026 - Global Outlook – By Type (Cloud Based, On-Premise), By Fraud Type (Card Testing, Credit Card Fraud, Friendly Fraud, Identity Theft, Merchant Fraud, Phishing, ...

Fraud Hunters Market Report 2026 - Global Outlook – By Type of Fraud (Financial Statement Fraud, Healthcare, Insurance And Banking Fraud, Consumer Fraud, Other Types Of Fraud), By Organization Size (SMEs, Large Organizat...

Insurance Fraud Detection Market Report 2026 - Global Outlook – By Component (Solution, Services), By Organization Size (Small And Medium-Sized Enterprises (SMEs), Large Enterprises), By Deployment Type (On-Premises, Clo...

Digital Payments Market Report 2026 - Global Outlook – By Mode Of Payment (Point Of Sale, Online Sale), By End-User Industry (Retail, Banking And Financial Service, Telecommunication, Government, Transportation, Others),...

Payment Security Market Report 2026 - Global Outlook – By Solution (Encryption, Tokenization, Fraud Detection And Prevention), By Services (Integration Services, Support Services, Consulting Services), By Organization Si...

Frequently Asked Questions

The Lung Cancer Screening market was valued at $3.33 billion in 2025, increased to $3.65 billion in 2026, and is projected to reach $5.24 billion by 2030.

The global Lung Cancer Screening market is expected to grow at a CAGR of 9.5% from 2026 to 2035 to reach $5.24 billion by 2035.

Some Key Players in the Lung Cancer Screening market Include, Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation .

Major trend in this market includes: Innovations In Artificial Intelligence (AI) Technology Enhance Early Detection And Diagnostic Precision In Chest Imaging. For further insights on this market. request a sample here

North America was the largest region in the lung cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us